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ABSTRACT  
Various polymeric materials have been used in medical devices, including 
blood-contacting artificial organs.  Contact between blood and foreign materials causes 
blood cell activation and adhesion, followed by blood coagulation.  Concurrently, the 
activated blood cells release inflammatory cytokines together with reactive oxygen 
species (ROS).  We have hypothesized that the suppression of ROS generation plays a 
crucial role in blood activation and coagulation.  To confirm this hypothesis, 
surface-coated polymers containing nitroxide radical compounds (nitroxide 
radical-containing polymer; NRP) were designed and developed.  The NRP was 
composed of a hydrophobic poly(chloromethylstyrene) (PCMS) chain in which 
2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPO) moieties were conjugated via 
condensation reaction of the chloromethyl groups in PCMS with the sodium alkolate 
group of 4-hydroxy-TEMPO.  Blood compatibility was investigated by placing 
NRP-coated beads in contact with rat whole blood.  The amount of ROS generated on 
PCMS-coated beads used as a control increased significantly with time, while 
NRP-coated beads suppressed ROS generation.  It is interesting to note that the 
suppression of inflammatory cytokine generation by NRP-coated beads was shown to 
be significantly higher than that of PCMS-coated beads.  Both platelet and leukocyte 
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adhesions on the beads were suppressed with increasing extent of the TEMPO 
component in the polymer.  From these results, it is confirmed that the suppression of 
ROS by NRP prevents inflammatory cytokine generation, which in turn results in the 
suppression of blood activation and coagulation on the beads. 
 
Keywords:   
Reactive oxygen species (ROS), Inflammation, Anti-thrombogenic biointerface, Blood 
compatibility, Cell activation 
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1. Introduction 
Various materials are employed in blood-contacting implantable and 
extracorporeal medical devices, such as artificial hearts, artificial blood vessels, 
hemodialyzers and apheresis columns.  Since most of those medical devices have 
poorly biocompatible surfaces, anticoagulants such as ethylenediaminetetraacetic acid 
(EDTA), hirudin, heparin, and warfarin are utilized for preventing thrombosis and 
embolism induced by the contact of blood with these medical devices [1].  Given the 
side effects of these anticoagulants, such as heparin-induced thrombocytopenia [2,3]; 
however, numerous efforts have been made to reduce the activation of blood in response 
to contact with material surfaces.  Suppression of such blood activation can effectively 
reduce the amount of anticoagulant required.  In order to improve the blood 
compatibility of material surfaces, a number of versatile methods have been applied.  
One of the most simple and important techniques is polymer coating using 
biocompatible polymers such as poly(ethylene glycol) [4], zwitterionic polymers [5-7], 
microphase-separated polymers [8,9], and poly(2-methoxyethyl acrylate) [10].  These 
approaches can drastically reduce the adsorption of serum proteins.  Protein adsorption 
triggers the activation of blood cells and blood coagulation on material surfaces through 
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a complex series of events, including the activation of platelets, leukocytes, complement, 
and the ﬁbrinolytic system [11].  Therefore, it has long been thought that the 
suppression of protein adsorption is highly important in the design of blood-compatible 
surfaces.  Nevertheless, even today, all blood-contacting devices cause thrombosis in 
long-term usage.  In fact, synthetic vascular grafts with inside diameters of less than 6 
mm cannot be used because they are prone to early thrombotic occlusion [12].  In the 
case of cardiac stents, drug-eluting stents have been developed for the inhibition of 
endothelial cell proliferation and restenosis, but even these stents were found to be 
thrombogenic [13,14].
  
Recently, gaseous molecules such as oxygen, nitric oxide, carbon monoxide and 
hydrogen sulfide are reported to play important roles for numerous biological events.  
New strategy utilizing these gaseous molecules has been proposed.  For example, 
polymer, which releases nitric oxide, shows high performance on the suppression of 
blood activation [15-18].  Interestingly, it has been revealed that blood–material 
interactions cause an increase in the levels of reactive oxygen species (ROS) and 
inflammatory cytokines, which is brought about by the activation of blood cells; this 
leads to blood coagulation and whole body inflammation (see Figure 1a) [19-21].  The 
excess ROS continuously amplify inflammation, thereby increasing the risk of 
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potentially life-threatening disorders [22].  Indeed, long-term hemodialysis therapy 
induces cardiovascular disease and atherosclerotic complications, which result in high 
morbidity and mortality in chronic renal failure patients [23].  However, there have 
been few reports with experimental evidence that ROS generation is related to 
inflammation in blood when in contact with the material surface, and the extent of ROS 
involvement in inflammation is not yet clear.
 
We have focused on the effect of ROS-scavenging materials in vivo and have 
used nitroxide radicals, such as 2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPO), which 
catalytically react with ROS [24-26] and can be used as electron spin resonance (ESR) 
probes in vivo [27,28].  Core–shell-type polymeric micelles containing nitroxide 
radicals have already been developed for the treatment of oxidative stress injuries and in 
vivo ESR imaging [29,30].  It has been confirmed that they not only strongly scavenge 
ROS in vivo or in vitro but also significantly prevent oxidative stress damage in an 
cerebral ischemia–reperfusion injury model in rats [31], renal ischemia–reperfusion 
injury model in mice [32] and a neuron cell line used as a model for Alzheimer’s disease 
[33,34], in which excess ROS is generated.  In the process, we have hypothesized that 
ROS-scavenging characteristics play a crucial role in blood activation and coagulation 
when blood comes in contact with material surfaces.  To validate our hypothesis, we 
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have designed and developed a hydrophobic nitroxide radical-containing polymer 
(NRP) composed of hydrophobic poly(chloromethylstyrene) (PCMS) chains in which 
TEMPO moieties were conjugated via condensation reaction of the chloromethyl 
groups in PCMS with the sodium alkolate group of 4-hydroxy-TEMPO (TEMPOL) (see 
Figure 1b).  In this paper, we describe the synthesis of the NRP homopolymer and its 
characterization in terms of blood compatibility. 
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2. Experimental Sections 
2.1 Materials 
2,2’-Azobisisobutyronitrile (AIBN; Kanto Chemical Co., Inc., Tokyo, Japan) was 
purified by recrystallization from methanol.  Chloromethylstyrene (CMS; > 95%), 
which was kindly provided by Seimi Chemical Co., Ltd. (Kanagawa, Japan), was 
washed three times with 20% NaOH aqueous solution to remove inhibitors, washed 
three times with water, and dried using sodium sulfate, followed by vacuum distillation 
under nitrogen atmosphere (2.0 mmHg, 56°C).  N,N-Dimethylformamide (DMF; 
Kanto Chemical Co., Inc., Tokyo, Japan) was purified by vacuum distillation under 
nitrogen atmosphere by a molecular sieve.  Tetrahydrofuran (THF), methanol, benzene, 
sodium hydride, 1,4-dioxane, n-decane (Kanto Chemical Co., Inc., Tokyo, Japan), 
TEMPOL, hypoxanthine (HX), xanthine oxidase (XOD; Aldrich Chemical Co., Inc., 
USA), and 2-methyl-6-p-methoxyphenylethynylimidazopyrazinone (MPEC; ATTO Co., 
Inc., Tokyo, Japan), and heparin (Mochida Pharmaceutical, Tokyo, Japan) were used 
without further purification.  
 
2.2 Synthesis of NRP 
After 1 mmol of AIBN was weighed into a flask, the inside of the reactor was 
degassed and filled with nitrogen gas.  The degassing–N2–purge cycle was repeated 
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three times.  CMS (100 mmol; 14.2 mL), 50 mL of 1,4-dioxane, and 3 mL of n-decane 
as an internal standard for gas chromatography, were then added to the flask under 
nitrogen atmosphere.  Polymerization was conducted for 18 h at 65°C in an oil bath.  
After the reaction, the obtained polymer was recovered three times by precipitation into 
1 L of methanol, followed by freeze-drying with benzene.  The yield of the obtained 
polymer was 63.2% (9.6 g).  Conversion of CMS was 61.5%, as determined by gas 
chromatography.  After 20 mg of the obtained PCMS (average molecular weight [Mw] 
= 2.6 × 10
4
, Mw/Mn = 2.1) was weighed into the flask, dry DMF (1 mL) was added to 
the flask under nitrogen atmosphere.  A solution of TEMPOL in dry DMF (1 mL) was 
added to a suspension of sodium hydride at molar quantity of TEMPOL in dry DMF (1 
mL); the mixture was stirred for 1 min, followed by addition to the PCMS solution in 
dry DMF under nitrogen atmosphere.  The mixture was stirred at room temperature for 
10 h.  The feed molar ratio of TEMPOL to chloromethyl groups in the PCMS 
homopolymer was systematically changed as summarized in Table 1.  Following this 
reaction, the mixture was directly used for coating glass beads.   
 
2.3 Preparation of NRP-coated beads (NRP beads) 
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Glass beads (average diameter: 200 μm) were washed by Soxhlet extraction with 
methanol, and glass beads (7 g) were immersed in the reaction mixture (3 mL) for 30 
min, followed by vacuum drying over night.  In order to remove unreacted TEMPOL 
from NRP beads, Soxhlet extraction was carried out with water for 8 h.  To determine 
the extent of TEMPO moieties in the obtained NRP, ESR spectroscopy of the extract 
and X-ray photoelectron spectroscopy (XPS) of the coated glass beads were used.  In 
ESR measurements, the extent of the TEMPO moieties in the obtained NRP was 
determined by the ESR signal area of TEMPOL initially fed into the reaction (fed 
TEMPOL), and unreacted TEMPOL in the extract (see Table 1 and Table S1).  In XPS, 
the extent of TEMPO coverage of the NRP beads was calculated from the ratio of the 
N1s (in TEMPO) and Cl2p (chloromethyl groups in the polymer) peak areas (see Table 
1 and Figure 3).  To confirm the coating of NRP on glass beads, coated substances on 
the glass beads were solubilized by chloroform after Soxhlet extraction and the ESR 
spectrum of the solubilized component in chloroform was measured. 
 
2.4 Measurement of the amount of superoxide generated by the HX/XOD model 
system 
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The superoxide-scavenging activity of NRP was measured using MPEC as a 
superoxide-reactive chemiluminescence (CL) producer.  After polymer-coated beads 
(50 mg) were added into each well of a 96-well micro-plate, 10 μL MPEC (1 mM) in 
ethanol, 50 μL XOD (0.1 U/mL), and HX (0.72 mM) were added to each well, followed 
by the immediate measurement of CL using a microplate reader (Wallac 1420 ARVOsx 
Multilabel counter; Perkin–Elmer Life Sciences, Tokyo, Japan) at 37ºC for 1 min. 
 
2.5 Animal  
Male Sprague–Dawley rats (body weight, 150-250 g; age, 5-6 weeks; Charles 
River, Japan) were maintained in the experimental animal facilities at the University of 
Tsukuba.  All experiments were performed according to the Guide for the Care and 
Use of Laboratory Animals at the University of Tsukuba.  Animals were anesthetized 
initially with pentobarbital sodium (20–30 mg/kg).  Thereafter, blood (9 mL) was 
collected by cardiopuncture from outside the body using heparinized syringes (50 
IU/mL, 1 mL), transferred to a siliconized tube, and kept on ice.  The final 
concentration of heparin was 5 IU/mL.   
 
2.6 Measurement of the amount of superoxide in blood 
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The amount of superoxide generated by contact between blood and polymer-coated 
beads was measured using MPEC.  After the polymer-coated beads (50 mg) were 
added to each well on the 96-well micro-plate, 50 μL of MPEC (1 mM) in ethanol and 
50 μL of diluted whole blood (2% w/w), which was diluted with saline, were added to 
each well, and the CL was immediately measured using a microplate reader at 37ºC for 
10 min. 
 
2.7 Measurement of the levels of inflammatory cytokines in plasma 
After the polymer-coated beads (100 mg) were added to the siliconized tube, 50 
μL of saline and 400 μL of heparinized rat whole blood were added to each tube, 
followed by incubation at 37ºC for 30 min with gentle rotation (1 rpm) by tube rotator 
(RT-5 TAITEC, Tokyo, Japan).  After incubation, plasma samples (100 μL) were 
obtained by centrifugation (2,000 rpm, 2 min) of the blood.  The plasma levels of 
tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) were measured using a 
commercially available enzyme-linked immunoassay kits for rat (Thermo Scientific 
Pierce Protein Research Products, Rockford, IL, USA), according to the manufacturer’s 
instructions. 
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2.8 Measurement of leukocyte and platelet levels in rat whole blood 
After the polymer-coated beads (100 mg) were added to the siliconized tube, 50 
μL of saline and 400 μL of heparinized rat whole blood were added to each tube, 
followed by incubation at room temperature for 30 min with gentle rotation (1 rpm) by 
tube rotator.  Suitable amount of coated beads was determined by the experiment of 
bead-weight dependency, as shown in Figure S1.  After incubation, the blood samples 
were transferred to an EDTA-coated tube and then placed on ice until further analysis.  
To prepare EDTA-coated tubes, EDTA solution (1.2 mg/mL, 10 μL) in saline was added 
to siliconized tube, followed by then dried under reducing pressure.  Blood cells in the 
sample were counted with a fully automatic hematology analyzer (Celltac α, 
MEK-6358; Nihon Kohden Co., Tokyo, Japan).  Relative platelet count (%) is 
expressed as the value relative to that without beads under the same experimental 
procedures; relative leukocyte count (%) is also calculated in a similar way.  
 
2.9 Scanning electron microscopy 
The NRP-coated glass beads were incubated with heparinized rat whole blood for 
30 min and rinsed with phosphate buffered saline (PBS) three times to remove weakly 
adhered blood cells; then, the adhered blood cells were fixed with a glutaraldehyde 
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solution (1.25 v/v%) in PBS at room temperature.  They were then dehydrated by 
treatment with gradual ethanol/distilled water mixture from 50% to 100% ethanol in 
steps of 10%.  After dehydration, the specimens were rinsed in a mixture (50/50) of 
ethanol/tertiary-butyl alcohol for 15 min, followed by incubation with tertiary-butyl 
alcohol twice for 15 min.  The resulting specimens were freeze-dried for 2 days and 
then platinum-coated using an ion sputter coater, followed by the measurement of 
scanning electron microscopy (SEM; JSM-6320F, JEOL). 
 
2.10 Instruments 
Size exclusion chromatography (SEC) was performed using TOSOH HLC-8120 
equipped with TSK gel columns (Super HZ4000 and Super HZ3000) and an internal 
refractive index (RI) detector.  THF with 5% (v/v) triethylamine was used as the eluent 
at a flow rate of 0.35 mL/min at 40°C.  The 
1
H NMR spectra were obtained using 
chloroform-d on a JEOL EX270 spectrometer at 270 MHz.  The 
1
H NMR spectra were 
collected with the following parameters: temperature, 25°C; numbers of scan, 64.  The 
ESR spectra were recorded at room temperature on a Bruker EMX-T ESR spectrometer 
operating at 9.7 GHz with a 100-kHz magnetic field modulation.  The spectra were 
collected with the following parameters: sweep width, 500 G; microwave power, 0.633 
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mW; receiver gain, 5.02×10
4
; time constant, 5.120 ms; and conversion time, 10.240 ms.  
Atomic concentration information was obtained by XPS (Thermo K-Alpha XPS, 
Thermo Fisher Scientific, West Palm Beach, FL, USA).  The instrument was equipped 
with a monochromatic Al-Kα X-ray source (hv = 1468.6 eV).  The XPS analysis 
chamber was evacuated to a pressure of 5 × 10
−7
 Pa before collecting the XPS spectra. 
Spectra were collected using an X-ray spot size of 400 μm and pass energy of 100 eV.  
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3. Results & discussion 
3.1 Synthesis of NRP and preparation of NRP beads 
     The PCMS homopolymer was synthesized by classical free-radical 
polymerization of CMS.  Figure S2 shows the SEC diagram and 
1
H NMR spectrum of 
the obtained PCMS.  The SEC diagram showed that the Mw and the molecular weight 
distribution were 26,000 and 2.1, respectively.  After the polymerization, the 
1
H NMR 
signal for the methylene protons of the chloromethyl group in PCMS at 4.5 ppm could 
still be detected in full; this indicated that any side reaction of the chloromethyl groups 
in PCMS can be ignored during polymerization.  Stable nitroxide radicals were 
conjugated as side chains of the homopolymer via the condensation reaction with the 
sodium alkolate group of TEMPOL.  In order to coat the obtained polymer onto glass 
beads, the beads were added to the reaction mixture; they were then dried under 
reducing pressure and purified using Soxhlet extraction with water in order to remove 
any unreacted TEMPOL.  To confirm the removal of unreacted TEMPOL, aliquots of 
the extract were collected at several time points during the Soxhlet extraction and their 
ESR spectra were measured, as shown in Figure S3.  Increasing ESR signal intensity 
was observed as a function of the washing time, with the signal intensity reaching the 
maximum at 7 h.  To confirm the coating of the polymer on glass beads, substances 
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coated on the glass beads were solubilized using chloroform after the Soxhlet extraction, 
and the ESR spectrum of the solubilized components in chloroform was measured.  As 
shown in Figure 2, in contrast to the clear triplet signal of the extract after Soxhlet 
extraction, the ESR spectrum of the component solubilized in chloroform showed a 
broad signal.  Since the ESR spectra of low-molecular-weight TEMPO derivatives 
generally show a clear triplet signal, because of an interaction between the 
14
N nuclei 
and the unpaired electron in the dilute solution, the sharp triplet signals of the extract 
show that only unreacted TEMPOL was successfully removed from the coated beads by 
Soxhlet extraction.  On the other hand, when a good solvent is used, the ESR signal of 
the nitroxide radical, which is present as side chains of the polymer, becomes broad 
owing to the spin–spin interaction of the stable radicals in the side chains [35]; the 
broad signal detected for the solubilized component in chloroform showed that NRP 
was firmly coated on the glass beads.  In addition, the NRP coating beads was 
confirmed by XPS.  As shown in Figure 3, the signals for nitrogen (N 1s) and chlorine 
(Cl 2p) in NRP and those for chlorine (Cl 2p) in the PCMS polymer were observed in 
conjunction with the signal for the glass beads; this shows that NRP or PCMS were 
tightly coated on the glass beads.  In order to determine the extent of the TEMPO 
moieties in the obtained NRP, the ESR and XPS data were quantitatively analyzed.  In 
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ESR measurements, the extent of the TEMPO moieties in the NRP was determined by 
the ESR signal area of fed TEMPOL and unreacted TEMPOL in the extract, as shown in 
Table S1.  Increasing the amount of fed TEMPOL results in an increase in the extent of 
TEMPO in the obtained NRP.  The XPS data also show the same trend as the ESR 
data; by increasing the amount of fed TEMPOL, the peak area of the N 1s signal of 
TEMPO increases and the peak area of the Cl 2p signal of PCMS decreases, as shown 
in Figure 3 and Table 1.  On the basis of these results, it was confirmed that the 
TEMPO moieties were successfully introduced into the polymer, and NRP was firmly 
coated on the glass beads. 
 
3.2 Suppression of blood activation by NRP beads 
Nitroxide radicals, in particular TEMPO derivatives, are known to not only 
catalytically scavenge superoxide radicals but also scavenge carbon-centered, peroxy 
radicals and hydroxyl radical [36].  In previous studies, we had developed polymeric 
micelles composed of an amphiphilic block copolymer possessing TEMPO moieties as 
side chains and confirmed their ROS-scavenging activity in vivo or in vitro [31-34].
  
Here, we first investigated whether nitroxide radicals on NRP beads can similarly 
scavenge superoxide generated by the HX/XOD model system.  As shown in Figure 4, 
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the quantity of superoxide did not decrease in the case of PCMS-coated beads (PCMS 
beads).  In contrast, NRP beads decreased the levels of superoxide depending on the 
TEMPO extent in the NRP beads, thus indicating that nitroxide radicals on the NRP 
beads work effectively as ROS scavengers.  To investigate the effect of NRP coating 
on the blood activation and coagulation, we used heparinized rat whole blood. 
Quantitative evaluation of the superoxide-scavenging activity of NRP beads was carried 
out after placing the coated beads in contact with diluted rat whole blood, as shown in 
Figure 5.  The quantity of superoxide in blood gradually increased with time when 
blood was in contact with PCMS beads, whereas NRP beads significantly suppressed 
superoxide generation, with the result that superoxide levels did not increase.  
Although it has been known that heparin interferes with leukocyte function even at 
lower doses [37], excessive ROS generation was observed in the case of PCMS beads as 
a control.  On the other hand, NRP beads completely scavenged ROS generated by the 
contact of diluted whole blood including heparin to bead surface.  The dependence of 
superoxide suppression on the extent of TEMPO in the polymer was then investigated.  
With increasing of TEMPO extent in the NRP beads, the levels of superoxide in the 
blood decreased, in a similar way to the results of the HX/XOD model system.  These 
results showed that ROS generation occurs in a predictable manner and that nitroxide 
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radicals on the beads are effective as ROS scavengers in blood.  Furthermore, we 
investigated the effect of ROS-scavenging activity by NRP beads on the generation of 
inflammatory cytokines.  As shown in Figure 6, placing rat whole blood in contact 
with PCMS beads leads to an increase in the levels of TNF-α and IL-1β in blood, 
whereas NRP beads significantly suppress the increase in the levels of inflammatory 
cytokines.  These results suggest that NRP significantly inhibits the generation of 
inflammatory cytokines, which is induced by contact of whole blood with coated beads, 
in comparison with PCMS beads.  This shows that the suppression of ROS generation 
leads to the inhibition of inflammation, which is induced by the contact of blood with 
foreign materials. 
 
3.3 Suppression of blood coagulation by the NRP beads 
The NRP beads were found to suppress ROS generation, which also results in the 
suppression of inflammatory cytokine production.  In order to investigate the effect of 
inhibition of blood activation on blood coagulation, rat whole blood was incubated with 
the coated beads and the change in the number of both platelets and leukocytes was 
measured using a cytometer.  Figure 7 shows the levels of platelets and leukocytes as a 
function of the extent of TEMPO in NRP beads.  The numbers of both platelets and 
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leukocytes decreased significantly in blood after incubation of rat whole blood with 
PCMS beads.  In contrast, with increases in the TEMPO extent in the polymer, this 
decrease in blood levels of platelets and leukocytes was suppressed, and this finding 
strongly suggested that NRP had suppressed blood coagulation.  SEM images of the 
coated beads were recorded to show the coagulation of blood.  As shown in Figure 8, 
high levels of blood coagulation were observed on the PCMS beads.  In contrast, the 
NRP coated surfaces were smooth, and almost no coagulation was observed on the 
surface.  From these results, it is clear that NRP coated surfaces can inhibit blood 
coagulation.  ROS scavenging character worked effectively on the suppression of 
blood cell activations. Freedman reported that NO rapidly reacts with ROS to result in 
suppression of blood activation [38].  The ROS scavenging character of NRP might 
influence the role of NO, which will be investigated further and will be published 
elsewhere.  Here, we emphasize that this finding is, to our knowledge, the first 
evidence that the use of ROS-scavenging materials as surfaces causes suppression of 
inflammation and blood coagulation.  On the basis of our results, we would like to 
propose that ROS-scavenging characteristics should be a key point in the design of 
biomaterials such as blood-contacting surfaces.   
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5. Conclusion 
   This study has shown that NRP was successfully synthesized and coated on glass 
beads.  When placing coated beads in contact with rat whole blood, NRP beads 
decreased the generation of ROS and inflammatory cytokines, thus resulting in the 
suppression of blood coagulation.  On the basis of these results, NRP is thus 
anticipated to be a new blood compatible-material that attenuates the activation of blood 
cells and blood coagulation. 
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Figure Legends 
 
Figure 1.  Schematic illustration of (a) the mechanism of blood activation and 
coagulation and (b) the NRP coated surface, which can scavenge ROS and inhibit blood 
coagulation. 
 
Figure 2.  ESR spectra of (a) extract and (b) chloroform solution, including the 
solubilized component from the surface of the glass beads following Soxhlet extraction. 
 
Figure 3.  The XPS spectra of (a) NRP beads-93%; (b) NRP beads-67%; (c) NRP 
beads-22%; (d) PCMS beads; and (e) bare glass beads. 
 
Figure 4.  The scavenging activity of NRP against superoxide generated by the 
HX/XOD model system. 
 
Figure 5.  The ROS-scavenging activity of NRP against superoxide generated by 
placing coated beads in contact with rat whole blood (2% w/w). (a) Time-course of 
chemiluminescence intensity after contact with NRP beads-93% (closed square) and 
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PCMS beads (open square) with rat whole blood. (b) Dependence of ROS-scavenging 
activity on the TEMPO extent of NRP.  (The bar graphs represent means ± SE for 6 
independent experiments.) 
 
Figure 6  Measurement of the levels of inflammatory cytokines (TNF-α and IL-1β) in 
whole blood stimulated by NRP beads-93% (black bar) and PCMS beads (white bar).  
(The bar graphs represent means ± SE for 6 independent experiments. *P <0.01 and 
**P <0.05, Student’s t-test) 
 
Figure 7  Change in the numbers of platelets (closed square) and leukocytes (open 
square) in blood as a function of the TEMPO extent of NRP. (The bar graphs represent 
means ± SE for 6 independent experiments.) 
 
Figure 8   SEM images of beads coated with (a) PCMS and (b) NRP after contact 
with rat whole blood for 30 min. 
 
Table Legend 
Table 1  TEMPO extent in NRP, as determined by XPS and ESR 
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